Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease

Strong epidemiological evidence and studies in models of Parkinson’s disease (PD) suggest that nicotine may be therapeutically beneficial in PD patients. However, a number of clinical trials utilizing nicotine in PD patients have had mixed results, indicating that either nicotine is not beneficial i...

Full description

Saved in:
Bibliographic Details
Main Authors: Brady T. Mannett, Braden C. Capt, Krista Pearman, Lori M. Buhlman, John M. VandenBrooks, Gerald B. Call
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2022/9291077
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548837902778368
author Brady T. Mannett
Braden C. Capt
Krista Pearman
Lori M. Buhlman
John M. VandenBrooks
Gerald B. Call
author_facet Brady T. Mannett
Braden C. Capt
Krista Pearman
Lori M. Buhlman
John M. VandenBrooks
Gerald B. Call
author_sort Brady T. Mannett
collection DOAJ
description Strong epidemiological evidence and studies in models of Parkinson’s disease (PD) suggest that nicotine may be therapeutically beneficial in PD patients. However, a number of clinical trials utilizing nicotine in PD patients have had mixed results, indicating that either nicotine is not beneficial in PD patients, or an important aspect of nicotine therapy was absent. We hypothesized that nicotine must be administered early in the adult fly life in order to have beneficial effects. We show that continuous early nicotine administration improves both climbing and flight deficiencies present in homozygous park25 mutant PD model Drosophila melanogaster. Using a new climbing assay, we identify several climbing deficiencies in this PD model that are improved or rescued by continuous nicotine treatment. Amongst these benefits, it appears that nicotine improves the ability of the park25 flies to descend the climbing vial by being able to climb down more. In support of our hypothesis, we show that in order for nicotine benefits on climbing and flight to happen, nicotine administration must occur in a discrete time frame following adult fly eclosure: within one day for climbing or five days for flight. This therapeutic window of nicotine administration in this PD model fly may help to explain the lack of efficacy of nicotine in human clinical trials.
format Article
id doaj-art-a45cfdc8957a48648cca036d269b419f
institution Kabale University
issn 2042-0080
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-a45cfdc8957a48648cca036d269b419f2025-02-03T06:12:57ZengWileyParkinson's Disease2042-00802022-01-01202210.1155/2022/9291077Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s DiseaseBrady T. Mannett0Braden C. Capt1Krista Pearman2Lori M. Buhlman3John M. VandenBrooks4Gerald B. Call5Arizona College of Osteopathic MedicineArizona College of Osteopathic MedicineDepartment of PharmacologyBiomedical Science ProgramDepartment of PhysiologyDepartment of PharmacologyStrong epidemiological evidence and studies in models of Parkinson’s disease (PD) suggest that nicotine may be therapeutically beneficial in PD patients. However, a number of clinical trials utilizing nicotine in PD patients have had mixed results, indicating that either nicotine is not beneficial in PD patients, or an important aspect of nicotine therapy was absent. We hypothesized that nicotine must be administered early in the adult fly life in order to have beneficial effects. We show that continuous early nicotine administration improves both climbing and flight deficiencies present in homozygous park25 mutant PD model Drosophila melanogaster. Using a new climbing assay, we identify several climbing deficiencies in this PD model that are improved or rescued by continuous nicotine treatment. Amongst these benefits, it appears that nicotine improves the ability of the park25 flies to descend the climbing vial by being able to climb down more. In support of our hypothesis, we show that in order for nicotine benefits on climbing and flight to happen, nicotine administration must occur in a discrete time frame following adult fly eclosure: within one day for climbing or five days for flight. This therapeutic window of nicotine administration in this PD model fly may help to explain the lack of efficacy of nicotine in human clinical trials.http://dx.doi.org/10.1155/2022/9291077
spellingShingle Brady T. Mannett
Braden C. Capt
Krista Pearman
Lori M. Buhlman
John M. VandenBrooks
Gerald B. Call
Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease
Parkinson's Disease
title Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease
title_full Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease
title_fullStr Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease
title_full_unstemmed Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease
title_short Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease
title_sort nicotine has a therapeutic window of effectiveness in a drosophila melanogaster model of parkinson s disease
url http://dx.doi.org/10.1155/2022/9291077
work_keys_str_mv AT bradytmannett nicotinehasatherapeuticwindowofeffectivenessinadrosophilamelanogastermodelofparkinsonsdisease
AT bradenccapt nicotinehasatherapeuticwindowofeffectivenessinadrosophilamelanogastermodelofparkinsonsdisease
AT kristapearman nicotinehasatherapeuticwindowofeffectivenessinadrosophilamelanogastermodelofparkinsonsdisease
AT lorimbuhlman nicotinehasatherapeuticwindowofeffectivenessinadrosophilamelanogastermodelofparkinsonsdisease
AT johnmvandenbrooks nicotinehasatherapeuticwindowofeffectivenessinadrosophilamelanogastermodelofparkinsonsdisease
AT geraldbcall nicotinehasatherapeuticwindowofeffectivenessinadrosophilamelanogastermodelofparkinsonsdisease